| Section | Provisional content |
|---|---|
| Note | No tool-retrieved citable contexts were available in this run, so all claims below are seed-anchored and require manual verification against the cited seed PMIDs before curation use. |
| Executive judgment | **Partially supported (provisional).** The seed evidence is consistent with biallelic or otherwise damaging **SYCE1** variants causing meiotic failure via synaptonemal-complex dysfunction, but confidence is limited because the underlying papers were not retrievable or independently verified in this session. |
| Evidence matrix (seed PMIDs + PubMed URLs) | **PMID:25062452** — https://pubmed.ncbi.nlm.nih.gov/25062452/ — familial human POI/primary amenorrhea with homozygous nonsense SYCE1 variant; **PMID:32402064** — https://pubmed.ncbi.nlm.nih.gov/32402064/ — model evidence for absent SYCE1/reduced transcript and synapsis-related infertility mechanism; **PMID:34718620** — https://pubmed.ncbi.nlm.nih.gov/34718620/ — SYCE1 variants reported to disrupt interaction with SYCP1 and/or C14ORF39/SIX6OS1, affecting SC assembly; **PMID:35718780** — https://pubmed.ncbi.nlm.nih.gov/35718780/ — human NOA cases with SYCE1 CNVs and pachytene-stage arrest on H&E/IF. |
| Clinical spectrum (46,XX vs 46,XY) | **46,XX:** primary ovarian insufficiency / primary amenorrhea. **46,XY:** non-obstructive azoospermia with reported pachytene-stage spermatogenic arrest on histology/immunofluorescence. Specific endocrine values, ovarian imaging, follicle depletion, semen details, and full biopsy-marker data were not retrievable here. |
| Variant / inheritance | Provisional inheritance model: **autosomal recessive / biallelic**. Seed evidence mentions a **homozygous nonsense variant c.613C>T**, additional damaging variants affecting SYCE1 interactions, and **SYCE1 CNVs**; exact zygosity/phasing, family counts, and classification details require full-text verification. |
| Mechanistic chain | Provisional chain: **biallelic SYCE1 loss/damaging variant -> reduced or absent SYCE1 -> disrupted interaction with SYCP1 and/or C14ORF39/SIX6OS1 -> synaptonemal-complex central element assembly failure -> homologous chromosome synapsis failure -> pachytene arrest/checkpoint activation -> germ-cell depletion -> 46,XX POI/primary amenorrhea or 46,XY NOA/spermatogenic arrest**. Intermediate links are supported mainly by seed model/in vitro evidence and need direct verification. |
| Diagnostics / management | Provisional practice implications: include **SYCE1** on infertility/POI/NOA testing panels with **CNV detection**; in 46,XY consider semen analysis, endocrine evaluation, and biopsy when indicated; in 46,XX assess ovarian reserve and POI biochemistry. Management is expected to follow standard POI/NOA care pathways, including hormone replacement for POI as indicated, fertility counseling, donor-oocyte discussion, and cautious consideration of micro-TESE/ICSI in NOA. |
| Ontology suggestions | **HPO:** Primary ovarian insufficiency; Primary amenorrhea; Female infertility; Azoospermia; Non-obstructive azoospermia; Spermatogenic arrest; Hypergonadotropic hypogonadism. **GO:** Meiotic cell cycle; Homologous chromosome pairing; Synaptonemal complex assembly; Meiotic recombination; Germ cell apoptotic process. **CL:** Primary oocyte; Spermatocyte; Pachytene spermatocyte; Germ cell. **Treatment/action terms:** Genetic testing; Genetic counseling; Hormone replacement therapy; Fertility preservation; Oocyte cryopreservation; Micro-TESE; ICSI; PGT-M. |
| Knowledge gaps | Major gaps reflect the retrieval block: no full-text verification, no figure/table access, no confirmed endocrine or histologic detail, uncertain CNV zygosity/phasing, and limited ability to separate direct human evidence from mouse or in vitro inference. No 2023-2024 studies could be identified or prioritized in this run. |
| Curator leads | After manual verification, consider annotating: (1) **meiotic synaptonemal-complex central element assembly defect** as the core mechanism; (2) dual-sex phenotype of **46,XX POI/primary amenorrhea** and **46,XY NOA/pachytene arrest**; (3) support for **loss-of-function and CNV** mechanisms; (4) partner-interaction mechanism involving **SYCP1** and **C14ORF39/SIX6OS1**. |


*Table: This table provides a seed-only, retrieval-blocked provisional report for SYCE1-related gametogenic failure. It organizes the key mechanistic, clinical, variant, and curation points while clearly noting that all claims require manual verification because no citable contexts were available.*